Advertisement

Advertisement

Advertisement

Autologous dendritic cell immunotherapy plus chemotherapy in metastatic castration-resistant prostate cancer

JAMA

MIR210HG is aberrantly expressed in the seminal plasma of varicocele patients and associated with varicocele-related dyszoospermia

Andrologia

Carboplatin-based adjuvant chemotherapy vs observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer

World Journal of Urology

Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: Experience at Dana Farber and in the PROCEED Registry

Prostate Cancer & Prostatic Diseases

Alcohol dehydrogenase expression patterns in normal prostate, benign prostatic hyperplasia, and prostatic adenocarcinoma in African American and Caucasian men

The Prostate

Lifestyle in pregnancy and hypospadias in sons: A study of 85,923 mother-son pairs from two Danish pregnancy cohorts

Clinical Epidemiology

Age-stratified outcomes after radical prostatectomy in a randomized setting (LAP-01): Do younger patients have more to lose?

World Journal of Urology

Hyperuricemia is an important risk factor of the erectile dysfunction: A systematic review and meta-analysis

Andrologia

Long-term residential exposure to air pollution and risk of testicular cancer in Denmark: A population-based case-control study

Cancer Epidemiology, Biomarkers & Prevention

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): A multicenter, open-label, phase 2 trial

The Lancet Oncology

Advertisement